ABSTRACT

The next-generation wireless pacemakers first became commercially available in 2012. A wireless pacemaker is 90% smaller than a transvenous pacemaker. There is no need for a chest incision or a visible pacemaker pocket.  A  wireless  pacemaker has  advantages  and  disadvantages  compared  to traditional devices. More studies are needed to determine how this affect long-term electrical performance, valve function, and left ventricular systolic function. The price of these devices and the choice of the patient are decisive. We expect this wireless, lead-free technology to offer long-term benefits by avoiding the recurring problems associated with other devices. This is particularly true of the shortcomings of current approaches, especially for lead-related vascular problems. This assessment will provide UK regulatory guidance as well as a detailed description of the currently available leadless pacing system. Development of next-generation lead-free devices capable of dual-chamber pacing and communication with subcutaneous defibrillators, expanding the scope of wireless pacing beyond 2022.

KEYWORDS: Leadless pacemaker; Precautions and safety information; UK Guidance on Leadless

Pacemaker; Marketed Leadless Pacemakers; Clinical study data.